Healthy Humans Clinical Trial
Official title:
Performance Assessment Study VitalSigns Camera
Verified date | August 2022 |
Source | Philips Clinical & Medical Affairs Global |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This Performance Assessment Study will focus on testing the performance of the VitalSigns Camera under various suboptimal use cases. The software makes it possible to measure the pulse rate (PR) and respiration rate (RR) without the device being in contact with the subject. The software delivers fast and accurate results (in less than one minute). Vital signs camera (VSC) product will be used via a demonstrator app on one of the smartphones during the study sessions (camera of the phone will be used by the VSC product). Devices will be provided by the researchers. The subject will be asked to perform a number of assignments with the software application. The study involves taking a number of measurements of the subject's PR using the VitalSigns Camera software application (which is installed on a smartphone or laptop). In this study only PR is measured and not RR as the latter parameter is not affected by the designed test cases. The total duration of the session will be approximately 1 hour. In total, approximately 30 healthy volunteers will participate in this study.
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | September 30, 2022 |
Est. primary completion date | July 22, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Healthy volunteer must 18 years or older - Participants willing to give informed consent - Willingness to have vital signs measured by a medical mobile application - Willingness to put on sunglasses - Willingness to put on facial makeup - Willingness to put on a face mask covering mouth and nose - Willingness to sit still up to 2 minutes per measurement Exclusion Criteria: - Individuals who are not able to read and understand the English language - Known allergic reaction to facial make-up - COVID-19 exclusion criteria: - Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing - Having been positively tested as infected with COVID-19 in the past 14 days - Travelled to or from high risk COVID-19 areas in the past 14 days - Been in contact with a (suspected) COVID-infected person in the past 14 days |
Country | Name | City | State |
---|---|---|---|
United States | Philips Research North America | Cambridge | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Philips Clinical & Medical Affairs Global |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary endpoint | To compare the Pulse Rate (Beats per Minute) measured by the VitalSigns Camera with the Pulse Rate measured by the reference device. | Each participants will have measurement for 1 hour on 1 day. Study will be completed within 1 week. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01398176 -
Immune Benefits From Mushroom Consumption
|
N/A | |
Completed |
NCT01248442 -
Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans
|
Phase 4 | |
Completed |
NCT00345215 -
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.
|
N/A | |
Completed |
NCT01716910 -
Effect of Synbiotic on Composition of Human Gut Microbiota and Production of Short and Branched-chain Fatty Acids
|
Phase 0 | |
Completed |
NCT01398150 -
Cranberry Enhances Human Immune Function and Reduces Illness
|
N/A | |
Completed |
NCT02291536 -
Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
|
N/A |